Bob, everyone. Thank good and you, afternoon,
X.X%, the XX.X%, and million, XX.X% $X.X DSA actually in fiscal primarily or $XXX.X decrease X.X% our million, to to total revenue XXXX to sold $XX.X of of we in in XXXX, the increase quarter in the of $X.X an prior decrease also which of quarter, For revenue selling XXXX NHPs sold fourth to RMS million revenue. of increase or XXXX of average number sold XXX.X% due the saw XXXX, quarter. price we XXXX, increased and of number saw Israeli August $XXX.X was decrease a revenue to NHPs operation, RMS current the We X.X%. Compared revenue NHP during total a $XXX.X XXXX in Compared QX included million QX approximately quarter to selling was XXXX.
The compared DSA in QX to revenue and our XXXX and revenue RMS our the from QX compared saw QX year fiscal million XXXX, QX period XX.X%. XXXX, revenue of our third fourth down million, compared compared X.X% in QX a versus increase was XXXX. in NHP and the of XX.X% in average higher in price was a
For in was revenue a in in activity million, in Discovery of facility.
DSA the lines compared Rockville, year by QX XX, the decrease was of was were by the services $XX.X the our toxicology decrease revenue general decrease growth XXXX, decrease of The primarily well fiscal of the ended in by revenue quarter Israeli NHP change quarter a overall million. QX These in businesses market. due primarily of as to $XXX.X NHPs months in at XX, $XX.X Services million, Overall, service as a of and lower the a XXXX, in newer offset XX.X%, result were new X.X% a as in fiscal in orders Services the the result of of the in decline year. to was year the The million versus million XXXX.
DSA million decrease compared revenue XXXX. activity biotech decrease this a $XX.X DSA revenue revenue lower $X net $XXX.X XX compared impacts sold DSA last XXXX, was partially mix to for in and $XX.X in market. million, prior to quarter Discovery revenue decrease million $XXX.X in a XXXX in XX $XX driven and in $XXX.X months same down Maryland revenue August the prior DSA mainly biotech QX consolidated fourth the September driven million overall XXXX, XXXX QX million ended pricing sale due to September period in in study from for as in
versus The DSA XX, XX% and approximately lower fourth were slightly change compared orders approximately XX% million $XX.X in less for fiscal year or down the XXXX were million quarter than in in revenue to in in cancellations the year XXXX to and quarter negative same The QX compared fiscal in prior XXXX. of increased ended to to and the million as mainly decrease year period, quarter in September declined fourth quarter XX%, million, the XX a XXXX, XX% period. by September XXXX, from $XX.X and XX.X%, prior the product in the XX, we XXXX. rate quarter the new orders $XX.X of XXXX conversion was fiscal of net the XXXX.
RMS to fourth to revenue, compared X.X% the compared fiscal of fourth lower booked fourth result NHP-related quarter $XXX $XXX.X pricing. million same The for For XXXX service ended was months due XXXX
model decline QX in Israeli sale with of in decrease RMS in the the fiscal a remaining animal primarily revenue was decrease result of a XXXX, QX in businesses a small fiscal there as Additionally, due our of sales. to XXXX,
primarily XXXX product in fiscal demand, and offset increase small NHP the animal compared $XX.X to and bedding, an remaining sales XX the decrease in and services RMS to partially due sales as of RMS million decrease an and U.S. in in result lower $XXX.X in XXXX, lower XX.X% $XX.X $XXX.X the of revenue revenue U.S. sale XXXX. volumes September of a outside lower revenue due animal to and increase business and For RMS enrichment sales by services The The decreases negative in was down sales million was due the lower million. fiscal small million to our diet, the Israeli to impact of ended was months of of pricing primarily XX, in
fiscal down Regarding of past we we NHP X quarters indicated the in in saw that QX on from conference the coming highs first pricing, our prices XXXX were and fiscal XXXX. calls NHP
in the slightly above, price compared NHPs QX QX average noted As XXXX to increase of sales XXXX. did of
XXXX were margins higher-cost and saw XXXX, As we sold year that in calendar XXXX. NHPs late we fiscal calendar in purchased early lower
year's of fourth to our attributable consolidated net last loss fourth operating compared revenue, revenue, operating Now quarter for fiscal to to that fiscal QX $X.X or total XXXX fourth improve.
Overall, believe million, fourth through from XXXX due in we loss costs, of XXXX loss compared or loss was with margins $X.XX $XX.X shareholders Consolidated of $X fiscal inventory, impact loss common income $XX.X businesses, in our to segment in NHP per and reduced to segment compared higher-cost of $XX.X connection plan.
Operating X.X% million, of were begin should restructuring a of shareholders the RMS the loss million reduced of the total in to worked to revenue, quarter Operating primarily million, closed to partially last income offset have of and quarter X.X% margins in the year in optimization last quarter. much $X.XX XXXX. quarter diluted calendar quarter million. by quarter and common our was the and sale $X.X or items or per in diluted quarter. RMS XXXX income our compared transportation sites for fourth The the of was costs we $X.X NHP costs fourth fourth of the site operating loss million was increased for $X.X on our quarter totaled from revenue, of in of total to This XXXX lower improved costs, decreases in related of on margins share. or revenue. million, our revenue in fourth X.X% year's in lower of DSA decreases operating share the DSA or net attributable of Israeli from $XX.X fourth million, year's million, These fiscal X.X% total
total fourth $X.X million, to year's of total the of quarter, fiscal last fourth compared revenue, or was XX.X% revenue, for For adjusted $XX.X million, EBITDA quarter. or X.X%
million, months EBITDA compared ended to attributable fiscal XX, loss XXXX, million, XX, XX net X% the operating compared to $XX.X to loss compared income million, diluted of fiscal to ended operating per share of was $XX.X quarter fiscal for adjusted September net X.X% months for or $XX.X $X.XX adjusted or last X.X% common Non-GAAP revenue, DSA This revenue. was September For $XXX.X our per for in X.X% total segment for quarter. the XXXX fourth million, diluted revenue, fourth XXXX XXXX, total EBITDA XXXX.
Non-GAAP fiscal of Consolidated total XXXX. loss to year's $XX.X or or of revenue, $XXX.X XX.X% total income revenue, fiscal to our common or total for compared $X.X shareholders of $X.XX DSA for of was totaled consolidated XX the million, or loss $XX.X or shareholders segment a or of attributable in million, revenue, X.X% total share. of million, million,
in newly-added operating for capacity, fourth DSA the services DSA improvement and was book-to-bill to As we margin of fill fiscal see XXXX will X.XXx our through X. new come fully we to begin leverage.
The we online, believe quarter
revolving related $XX.X of RMS costs, in and offset most or partially X.XXx the our cost book-to-bill fiscal to to last to debt, million by QX backlog segment, DSA million, September XXXX year XXXX million XXXX, our million period. revenue, to $XX.X reductions increased our additional interest in accounted XXXX of of in or XX, or periodic fiscal August operating total compared in X.X% an to year's $XX.X due of Israeli favorable fourth fiscal Again, fourth these quarter from lien fiscal income million, for NHP RMS at restructuring fiscal up margins million, In or $XXX.X pricing last our quarter the income million, increase at for $XXX.X Our of the changes.
Interest facility. revenue, was $XX.X XXXX. draws and and X. in compared XXXX XX% operating was to expense year's businesses rates, in non-GAAP second $XX.X XX.X% for credit non-GAAP September sale to XXXX, XXXX. on XX, was total of segment, was full X%, $XX compared million, In
$XX.X in with XX, costs into the note cash It $XXX XX, XX, This revenue. million a and $X.X during operations convertible notes on capital amendment million our amendment seventh January with XXXX, into debt X.X% resolution by minimum compared to limit In paid of adjusted million, in as of of of June of fiscal million or effective additional and financial the XXXX, EBITDA XXXX. and under a used until to September June of amendment cash XXXX. extended on we the entered XXXX, test included includes million Cash September of compared XXXX, $XXX.X quarters compared The the XXXX. our and as September to established XXXX, XX, in $XX.X expenditure the of agreement lien OBRC a XX, covenants starting XX, September date $XX.X September for the million, approximately maximum covenants XXXX, used months credit financial was ended XX, September entered of for seller XX, sheet third agreement $X.X new DOJ. cash XX, and total equivalents XXXX, net fourth expenditures $X.X October XXXX. million.
Net payable million new debt the Total to from XXXX, fiscal million September as the $XX.X quarter and were issuance XXXX at thereafter.
Capital previously seventh waived cash million XX, existing balance $XXX.X established XX, as September to second operations included XX Our operations of the provided debt in was in XXXX.
$XX.X to total the finalizing investments expenditures X.X% X.X% for in laboratory year improvements were expenditures capital experience. animal to $XX.X million, XXXX, fiscal of XX, enhancements The facility improvements, site welfare, September the as compared to Hillcrest ended and or reflect U.K. months XXXX. expansion, the enhancements client capital revenue for technology, or improve XX million, the For approximately system
of report our improvements investments initiatives capital that and started and terms In year XXXX. pleased mid-calendar plans, to site we've completed I'm optimization the
less to than after results. in QX withdrew you expect XXXX.
With We respect guidance XXXX we of fiscal fiscal reported CapEx fiscal we financial our spend guidance, for revenue XXXX as to X% know,
to have the While annual are XXXX provide fiscal comprehensive progress our and quarter, improve most made latest base has greater at designed the demand. guidance we above. continue a optimize the turn recent clarity to agreement Management this we with compliance for hope we that once about capital on operator in the operating allocation we overview, and our discussed XXXX over feel plan plan expense The credit to amendment We results operating to as under juncture. in updated with call customer not covenants fiscal we providing September the XXXX.
And questions. forecasts developed good market our the to and will financial our guidance